Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer
10.18632/oncotarget.11596
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/174106 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-174106 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1741062024-04-25T02:39:09Z Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer Wong A.L.A. Sundar R. Wang T.-T. Ng T.-C. Zhang B. Tan S.-H. Soh T.I.P. Pang A.S.L. Tan C.-S. Ow S.G.W. Wang L. Mogro J. Ho J. Jeyasekharan A.D. Huang Y. Thng C.-H. Chan C.-W. Hartman M. Iau P. Buhari S.A. Goh B.-C. Lee S.-C. MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE DIAGNOSTIC RADIOLOGY DEAN'S OFFICE (MEDICINE) PHARMACY DUKE-NUS MEDICAL SCHOOL SURGERY PHARMACOLOGY cyclophosphamide doxorubicin sunitinib anthracycline antineoplastic agent contrast medium cyclophosphamide doxorubicin indole derivative pyrrole derivative sunitinib tumor marker adult aged anemia Article breast cancer cancer chemotherapy clinical article controlled study drug efficacy drug response drug safety febrile neutropenia female fever human human tissue immunohistochemistry lethargy leukopenia lymph vessel multiple cycle treatment neutropenia nuclear magnetic resonance imaging phase 1 clinical trial phase 2 clinical trial randomized controlled trial stomatitis breast tumor clinical trial disease free survival drug administration middle aged neoadjuvant therapy preoperative period treatment outcome Adult Aged Anthracyclines Antineoplastic Agents Biomarkers, Tumor Breast Neoplasms Contrast Media Cyclophosphamide Disease-Free Survival Doxorubicin Drug Administration Schedule Female Humans Immunohistochemistry Indoles Magnetic Resonance Imaging Middle Aged Neoadjuvant Therapy Preoperative Period Pyrroles Treatment Outcome 10.18632/oncotarget.11596 Oncotarget 7 39 64089-64099 2020-09-03T10:31:07Z 2020-09-03T10:31:07Z 2016 Article Wong A.L.A., Sundar R., Wang T.-T., Ng T.-C., Zhang B., Tan S.-H., Soh T.I.P., Pang A.S.L., Tan C.-S., Ow S.G.W., Wang L., Mogro J., Ho J., Jeyasekharan A.D., Huang Y., Thng C.-H., Chan C.-W., Hartman M., Iau P., Buhari S.A., Goh B.-C., Lee S.-C. (2016). Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer. Oncotarget 7 (39) : 64089-64099. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.11596 19492553 https://scholarbank.nus.edu.sg/handle/10635/174106 Unpaywall 20200831 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
cyclophosphamide doxorubicin sunitinib anthracycline antineoplastic agent contrast medium cyclophosphamide doxorubicin indole derivative pyrrole derivative sunitinib tumor marker adult aged anemia Article breast cancer cancer chemotherapy clinical article controlled study drug efficacy drug response drug safety febrile neutropenia female fever human human tissue immunohistochemistry lethargy leukopenia lymph vessel multiple cycle treatment neutropenia nuclear magnetic resonance imaging phase 1 clinical trial phase 2 clinical trial randomized controlled trial stomatitis breast tumor clinical trial disease free survival drug administration middle aged neoadjuvant therapy preoperative period treatment outcome Adult Aged Anthracyclines Antineoplastic Agents Biomarkers, Tumor Breast Neoplasms Contrast Media Cyclophosphamide Disease-Free Survival Doxorubicin Drug Administration Schedule Female Humans Immunohistochemistry Indoles Magnetic Resonance Imaging Middle Aged Neoadjuvant Therapy Preoperative Period Pyrroles Treatment Outcome |
| spellingShingle |
cyclophosphamide doxorubicin sunitinib anthracycline antineoplastic agent contrast medium cyclophosphamide doxorubicin indole derivative pyrrole derivative sunitinib tumor marker adult aged anemia Article breast cancer cancer chemotherapy clinical article controlled study drug efficacy drug response drug safety febrile neutropenia female fever human human tissue immunohistochemistry lethargy leukopenia lymph vessel multiple cycle treatment neutropenia nuclear magnetic resonance imaging phase 1 clinical trial phase 2 clinical trial randomized controlled trial stomatitis breast tumor clinical trial disease free survival drug administration middle aged neoadjuvant therapy preoperative period treatment outcome Adult Aged Anthracyclines Antineoplastic Agents Biomarkers, Tumor Breast Neoplasms Contrast Media Cyclophosphamide Disease-Free Survival Doxorubicin Drug Administration Schedule Female Humans Immunohistochemistry Indoles Magnetic Resonance Imaging Middle Aged Neoadjuvant Therapy Preoperative Period Pyrroles Treatment Outcome Wong A.L.A. Sundar R. Wang T.-T. Ng T.-C. Zhang B. Tan S.-H. Soh T.I.P. Pang A.S.L. Tan C.-S. Ow S.G.W. Wang L. Mogro J. Ho J. Jeyasekharan A.D. Huang Y. Thng C.-H. Chan C.-W. Hartman M. Iau P. Buhari S.A. Goh B.-C. Lee S.-C. Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer |
| description |
10.18632/oncotarget.11596 |
| author2 |
MEDICINE |
| author_facet |
MEDICINE Wong A.L.A. Sundar R. Wang T.-T. Ng T.-C. Zhang B. Tan S.-H. Soh T.I.P. Pang A.S.L. Tan C.-S. Ow S.G.W. Wang L. Mogro J. Ho J. Jeyasekharan A.D. Huang Y. Thng C.-H. Chan C.-W. Hartman M. Iau P. Buhari S.A. Goh B.-C. Lee S.-C. |
| format |
Article |
| author |
Wong A.L.A. Sundar R. Wang T.-T. Ng T.-C. Zhang B. Tan S.-H. Soh T.I.P. Pang A.S.L. Tan C.-S. Ow S.G.W. Wang L. Mogro J. Ho J. Jeyasekharan A.D. Huang Y. Thng C.-H. Chan C.-W. Hartman M. Iau P. Buhari S.A. Goh B.-C. Lee S.-C. |
| author_sort |
Wong A.L.A. |
| title |
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer |
| title_short |
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer |
| title_full |
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer |
| title_fullStr |
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer |
| title_full_unstemmed |
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer |
| title_sort |
phase ib/ii randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer |
| publishDate |
2020 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/174106 |
| _version_ |
1800914214379847680 |